Press release
CD Bioparticles Launches Innovative Organoid Construct Kit to Advance Drug Discovery
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its Organoid Construct Kits [https://www.cd-bioparticles.net/medical-device] to the scientific community to facilitate the construction of complex organoid models, enabling researchers to advance drug discovery and development, disease modeling, and personalized medicine.
Organoids are microscopic organ-like structures derived from stem cells that have become powerful tools for studying disease mechanisms, drug efficacy and toxicity. CD Bioparticles now offers a variety of Organoid Construction Kits to simplify the process of generating organoids and enable scientists to accelerate their research. This comprehensive portfolio of Organoid Construction Kits includes Cervical Cancer Organoid Construct Kit, Gastric Cancer Organoid Construction Kit, Intestinal Organoid Construction Kit, Lung Cancer Organoid Construction Kit, and Ovarian Cancer Organoid Construction Kit.
These kits include a complete set of optimized reagents, protocols and technical support to guide users through the entire organoid construction process. For example, the ready-to-use Intestinal Organoid Construction Kit can maximize the the satisfaction of customer's experimental needs, provide the greatest convenience, and reduce the time spent on non-experimental processes. The Organoid Construction Kit is divided into four modules: Part I: Tissue Dissociation and Organoid Construction; Part II: Organoid Transfer; Part III: Organoid Freezing; and Part IV: Organoid Recovery.
The products provide customers with consumables and reagents needed for the entire experimental process, saving time wasted in purchasing various reagents and consumables. Customers only need to equip the product with routine instruments and consumables to complete the entire experimental process of intestinal cancer organoid construction. With its user-friendly protocol and high-quality components, researchers can now streamline their organoid development process and achieve reproducible results.
The Organoid Construction Kit is the latest addition to CD Bioparticles' extensive portfolio of drug delivery products and services. The company also offers a wide range of 3D cell culture substrates, engineered tissue scaffolds, and other biomaterials for various applications in drug delivery, diagnostics, and research. With these tools, the company can provide researchers with custom solution to the challenges they often face in creating optimal cell growth environments, acquiring sufficient lab materials, and developing biocompatible support structures for tissue regeneration.
In addition, CD Bioparticles offers specialized delivery techniques, tissue engineering scaffold design and modification, and advanced technology platforms to accelerate research. The new products reflect the company's commitment to providing cutting-edge tools that support scientists in their endeavors to advance biomedical research and empower researchers to explore the complexities of human biology and develop novel therapeutic approaches.
CD Bioparticles is dedicated to delivering quality solutions to meet the evolving needs of the scientific community. For more information about the Organoid Construct Kits, please visit https://www.cd-bioparticles.net/medical-device.
About CD Bioparticles
CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.
Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioparticles-launches-innovative-organoid-construct-kit-to-advance-drug-discovery]
State: New York
Country: United States
Website: https://www.cd-bioparticles.net/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD Bioparticles Launches Innovative Organoid Construct Kit to Advance Drug Discovery here
News-ID: 3636725 • Views: …
More Releases from ABNewswire
COOLSMILE Launches on Kickstarter with a New Approach to Personal Cooling
Now available on Kickstarter, the second-generation COOLSMILE delivers colder air and significantly longer cooling than conventional portable coolers.
Image: https://www.abnewswire.com/upload/2026/08/be1709887eca4e87a82700c3614ed2de.jpg
BUSAN, South Korea - August 24, 2026 - As temperatures continue to rise worldwide, demand for practical personal cooling solutions is increasing. The second-generation COOLSMILE, now available on Kickstarter, [https://www.kickstarter.com/projects/coolsmilellc/coolsmile-the-portable-personal-cooler-reinvented] introduces a different approach to portable cooling by freezing the entire cooling body instead of only a small cooling core. This innovative…
SH Media Launches Talking Website, an AI Chatbot Service for Small Businesses Bu …
Digital marketing consultant Sascha Hoffmann from SH-Media.co has launched Talking-Website.com, a done-for-you AI chatbot service for small businesses that replaces the standard agency retainer model with a single build fee. The service deploys custom-trained AI voice agents on small business websites, handling customer inquiries, qualifying leads, and booking appointments automatically.
Furstenberg, Germany - August 24, 2026 - Small businesses running ads, investing in SEO, and maintaining websites are generating traffic they…
Smart Separation Offers Divorce Mediation in Toronto for Couples Seeking an Alte …
Toronto family mediation service helps separating spouses address parenting, support, property and separation issues through a structured and private process.
Toronto, Ontario - August 24, 2026 - Smart Separation is helping Toronto couples navigate separation and divorce through a more cooperative approach with its divorce mediation in Toronto [https://smartseparation.ca/divorce-mediation-toronto/] services.
Rather than immediately turning family disputes into lengthy court proceedings, mediation gives separating spouses an opportunity to discuss important decisions with the…
A New Era Begins: SFV Chargers Open Inaugural Season with a Clean Sweep
SAN FERNANDO VALLEY, CA - August 24, 2026 - A new organization. A new season. A new standard. The SFV Chargers officially kicked off their inaugural season in impressive fashion, earning victories across all five divisions and beginning the year a perfect 5-0.
For a first-year organization built from the ground up, opening weekend represented much more than wins and losses. It was the first opportunity to see months of planning,…
More Releases for Organoid
Advancing Human Hair Research with Skin Organoid Models
Hair research plays a critical role in addressing common conditions such as androgenetic alopecia, hair thinning, and hair graying. Yet, despite decades of study, the development of effective therapies has been slow. One major reason is the limited ability of conventional research models to accurately reflect the complexity of human hair follicle biology.
Recent advances in human skin organoid technology are reshaping this landscape. Skin organoids provide a three-dimensional, human-relevant platform…
4Dcell Achieves 95% Organoid Reproducibility Breakthrough With Patented Anchorin …
4Dcell announced that its SmartSphero plates have achieved over 95% reproducibility in organoid size and shape, while reducing organoid loss during medium exchanges to below 12%, a significant improvement over the 86% loss seen in traditional unanchored systems. This breakthrough addresses a persistent challenge in pharmaceutical drug screening and safety testing, where inconsistent organoid cultures have often hindered data reliability.
The company's patented Anchoring Point Technology (APT®) allows researchers to culture…
Organoid Culture Medium Research:the global Organoid Culture Medium market size …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Organoid Culture Medium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
…
Organoid Technology Market Size, Growth, In-depth Analysis, Research Report Fore …
The organoid technology market is estimated to grow at a CAGR of 27.12% during the forecast period.
The prime factors propelling the growth of the organoid technology market are increasing demand for personalized medicine, drug discovery and development, and regenerative medicine.
As per the report, the organoid technology market is expected to grow rapidly during the forecast period.
Organoids are three-dimensional cell cultures that mimic the structure and function of human organs, making…
Organoid Technology Market Trends, Future Demands, Growth Factors, Emerging Tech …
The global Organoids and Spheroids Market size was valued at $516.6 million in 2021 and is projected to reach $1.2 billion by 2031, growing at a CAGR of 8.5% from 2022 to 2031.
Organoid technology bridges the gap between conventional two-dimensional cell line culture and in vivo models. The near-physiological technology can virtually recapitulates organ development and human diseases, such as infectious diseases, genetic abnormality and even cancers.
Between traditional two-dimensional cell…
Organoids Market Driven By Definigen, Organoid Therapeutics, Hubrecht Organoid T …
The scope of the organoids market includes type, application, source, and region. The organoids market is analyzed based on regions, such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the organoids market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.…
